<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Arch Pharm Pract</journal-id>
      <journal-id journal-id-type="publisher-id">archivepp.com</journal-id>
      <journal-id journal-id-type="publisher-id">Arch Pharm Pract</journal-id>
      <journal-title-group>
        <journal-title>Archives of Pharmacy Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2320-5210</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">archivepp.com-1240</article-id>
      <article-id pub-id-type="doi">10.51847/n2YuL8SLvh</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Electronic Clinical Progress Notes as Performance Indicators in Clinical Pharmacy: A Validation Study</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Silva</surname>
                <given-names>Gustavo Cassiano da</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Vettore</surname>
                <given-names>Mario Vianna</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Fuller</surname>
                <given-names>Renato</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Ardelean</surname>
                <given-names>Lavinia Cosmina</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Postgraduate in Health Sciences, Medical School, Federal University of Goiás, Goiânia, Goiás, Brazil.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="mariovettorevianna@gmail.com">mariovettorevianna@gmail.com</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>07</day>
        <month>10</month>
        <year>2025</year>
      </pub-date>
      <volume>16</volume>
      <issue>4</issue>
      <fpage>17</fpage>
      <lpage>20</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Archives of Pharmacy Practice
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Hospital clinical pharmacy teams contribute to safer, more effective, and cost-conscious medication use. Evaluating the extent and impact of these services is vital for ensuring care quality, but conventional performance tracking through manual reporting is resource-intensive. This study investigated whether electronic medical record (EMR) progress note counts could reliably indicate clinical pharmacy activity. A sample of 300 adult patient admissions across three Australian hospitals (May–November 2021) was examined. Pharmacy-authored EMR notes were categorized according to their titles and the interventions documented. Using a manual audit as the reference standard, the validity of note counts was assessed via sensitivity, specificity, and positive predictive value. Among 861 audited notes, entries labeled PMM Medication History, PMM Medication Review, and PMM Discharge Medications exhibited strong agreement with manually verified interventions, showing high specificity and predictive accuracy (&gt; 98%) and sensitivities of 98%, 90%, and 89%, respectively. These findings support the use of EMR progress note counts as an accurate, efficient measure of clinical pharmacy service delivery. This approach offers a scalable solution for hospitals seeking streamlined performance assessment. The study received ethical clearance from the Central Adelaide Local Health Network Human Research Ethics Committee (Ref. 16357) and the University of South Australia Human Research Ethics Committee (Ref. 205782), in line with national ethical standards. </p>
      </abstract>
      <kwd-group>
                <kwd>Clinical pharmacy</kwd>
                <kwd>Hospital services</kwd>
                <kwd>EMR</kwd>
                <kwd>Performance evaluation</kwd>
                <kwd>Medication management</kwd>
                <kwd>Healthcare quality</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>